
Bluejay Diagnostics, Inc. functions as a company specializing in medical diagnostic solutions. A key offering is their Symphony platform, an advanced technological system. This platform is composed of the Symphony analyzer, which skillfully orchestrates the processing of whole blood, the isolation of biomarkers, and the preparation of immunoassays using non-contact centrifugal force. It also includes the Symphony Cartridge, which comes pre-loaded with essential reagents and components. The company additionally provides the ALLEREYE diagnostic test, a convenient, on-site device for quickly identifying allergic conjunctivitis. Bluejay Diagnostics is also progressing with the development of Symphony IL-6 tests, intended for monitoring disease advancement in critical care environments. Furthermore, they are actively creating additional diagnostic tests for their Symphony platform, such as those aimed at detecting myocardial infarction (heart attack) and congestive heart failure. Bluejay Diagnostics, Inc. was founded in 2015 and is headquartered in Acton, Massachusetts.
Loading…
Data from Twelve Data. Prices may be delayed.
No analyst coverage available.
ADP Employment Report
8:15 AM ET
Initial Jobless Claims
8:30 AM ET
Employment Situation (NFP)
8:30 AM ET
G.19 - Consumer Credit
3:00 PM ET

Bitcoin (BTC)
77,762 +1.08%

Ethereum (ETH)
2,299 +2.17%

Solana (SOL)
94 +1.97%

Corporate PresentationOct 13, 2026
Bluejay Diagnostics, Inc. (BJDX) is a medical device company specializing in diagnostic solutions. Their Symphony platform utilizes an analyzer and pre-loaded cartridges for automated whole blood processing and immunoassay preparation. BJDX also offers the ALLEREYE test for allergic conjunctivitis. The company is developing Symphony IL-6 tests for critical care and additional diagnostics for myocardial infarction and congestive heart failure.
Generated by AI